Lymphedema Associated With Kaposi’s Sarcoma: A Case Report

Year 2026, Volume: 9 Issue: 1, 19 - 23, 16.03.2026

İlknur Mazı , Ela Tarakci , Ahmet Akgül

https://izlik.org/JA46SJ55WG

Abstract

Lymphedema is a common but often underemphasized complication of Kaposi’s Sarcoma (KS). During the oncological process, it directly affects patients’ functional capacities, quality of life, and adherence to treatment. The aim of this case report is to demonstrate the clinical and functional outcomes of lymphedema secondary to KS. A 56-year-old male patient was diagnosed with KS and started on systemic chemotherapy and antiretroviral therapy. Doppler ultrasonography revealed no signs of venous insufficiency or thrombosis in the right lower extremity; however, segmental slowing of lymphatic flow and an increase in subcutaneous edema were observed. These findings were evaluated as consistent with lymphatic obstruction. The patient underwent a rehabilitation program consisting of manual lymph drainage, compression therapy, exercise, and skin care for a total of 18 sessions over 6 weeks, three days per week. Each session lasted approximately 45–60 minutes. The exercise program included 30 minutes of brisk walking five days a week, ankle pumping exercises to enhance peripheral circulation, and diaphragmatic breathing (10 repetitions × 3 sets). Lymphedema was assessed using tape measurement for limb circumference, tonometry for skin elasticity, the 6-Minute Walk Test (6MWT) for functional capacity, and the Lymphedema Quality of Life Questionnaire (LYMQOL) for quality of life. The applied rehabilitation program was shown to improve edema control and skin elasticity while simultaneously enhancing the patient’s functional capacity and overall quality of life.

Keywords

lymphedema , Kaposi Sarcoma , Physiotherapy , rehabilitasyon

Ethical Statement

Ethics committee approval was not required for this study.İnformed consent was obtained from the patient.

Supporting Institution

Not applicable

Kapoşi Sarkomu İle İlişkili Lenfödem: Bir Olgu Sunumu

https://izlik.org/JA46SJ55WG

Abstract

Lenfödem, Kapoşi Sarkomu’nun (KS) sık karşılaşılan ancak yeterince vurgulanmayan bir komplikasyonudur. Onkolojik süreçte hastaların fonksiyonel kapasitelerini, yaşam kalitesini ve tedaviye uyumunu doğrudan etkiler. Bu olgu sunumunun amacı, KS’ye bağlı gelişen lenfödemin hasta üzerindeki klinik ve fonksiyonel sonuçlarını ortaya koymaktır. 56 yaşında erkek hasta, KS tanısı almış ve sistemik kemoterapi ile antiretroviral tedaviye başlanmıştır. Yapılan Doppler ultrasonografide, sağ alt ekstremitede venöz yetmezlik ve tromboz bulgusuna rastlanmamış; ancak lenfatik akışta segmental düzeyde yavaşlama ve subkutanöz ödem artışı izlenmiştir. Bu bulgular, lenfatik tıkanıklıkla uyumlu olarak değerlendirilmiştir. Hastaya toplamda 6 hafta süren, haftada 3 gün olmak üzere toplam 18 seanslık lenf drenajı, kompresyon tedavisi, egzersiz ve cilt bakımı içeren bir rehabilitasyon programı uygulanmıştır. Seanslar yaklaşık 45-60 dakika sürmüştür. Egzersiz programı: 30 dakika, haftada 5 gün tempolu yürüyüş, ayak bileği çevresinde dolaşımı artırmaya yönelik pompa egzersizleri ve diyaframatik solunum (10 tekrar x 3 set) şeklinde düzenlenmiştir. Lenfödemin değerlendirilmesinde mezura ile çevre ölçümü, cilt esnekliği için tonometre ve fonksiyonel kapasite için 6 Dakika Yürüme Testi (6DYT) yaşam kalitesi için lenfödem yaşamm kalitesi ölçeği LYMQOL kullanılmıştır. Uygulanan rehabilitasyon programı ödem kontrolü ve cilt elastikiyetinde iyileşme sağlayarak aynı zamanda hastanın fonksiyonel kapasitesi ile birlikte yaşam kalitesini artırdığını göstermektedir.

Keywords

lenfödem , kapoşi sarkomu , fizyoterapi , rehabilitasyon

Ethical Statement

Hastadan bilgilendirilmiş onam alınmıştır

Supporting Institution

Destekleyen kurum yoktur.

References

• Antman, K., & Chang, Y. (2000). Kaposi's sarcoma. New England Journal of Medicine, 342(14), 1027–1038. https://doi. org/10.1056/NEJM200004063421407
• Ensoli, B., & Stürzl, M. (1998). Kaposi’s sarcoma: A result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine & Growth Factor Reviews, 9(1), 63–83. https://doi. org/10.1016/S1359-6101(97)00037-3
• Sander, A. P., Hajer, N. M., Hemenway, K., & Miller, A. C. (2002). Upper-extremity volume measurements in women with lymphedema: A comparison of measurements obtained via water displacement with geometrically determined volume. Physical Therapy, 82(12), 1201–1212. https:// doi.org/10.1093/ptj/82.12.1201
• Devoogdt, N., Geraerts, I., Van Kampen, M., De Vrieze, T., Vos, L., Neven, P., Vergote, I., Christiaens, M. R., Thomis, S., & De Groef, A. (2018). Manual lymph drainage may not have a preventive effect on the development of breast cancerrelated lymphoedema in the long term: a randomised trial. Journal of physiotherapy, 64(4), 245–254. https://doi. org/10.1016/j.jphys.2018.08.007
• Ruocco, V., Ruocco, E., Tornesello, M. L., Gambardella, A., Wolf, R., & Buonaguro, F. M. (2013). Kaposi's sarcoma: Etiology and pathogenesis, inducing factors, and classical treatment options. Journal of Dermatological Science, 73(3), 151–157. https:// doi.org/10.1016/j.jdermsci.2013.10.001
• Stout Gergich, N. L., Pfalzer, L. A., Mc- Garvey, C., Springer, B., Gerber, L. H., & Soballe, P. (2008). Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer, 112(12), 2809–2819. https://doi. org/10.1002/cncr.23494
• ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. (2002). ATS statement: Guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine, 166(1), 111–117. https://doi.org/10.1164/ rccm.166.1.at1102
• Keeley, V., Crooks, S., Locke, J., Veigas, D., Riches, K., & Hilliam, R. (2010). A quality of life measure for limb lymphedema (LYMQOL). Journal of Lymphoedema, 5(1), 26–37.
• Akgul, A., Mazi, İ., Aydin, G., et al. (2025). The effect of muscles in the treatment of lower limb lymphedema: Respiratory muscles or leg muscles? Supportive Care in Cancer, 33, 375. https://doi.org/10.1007/ s00520-025-09436-3
• Pantanowitz, L. (2008). Kaposi sarcoma: A review. Journal of Clinical Pathology, 61(12), 1377–1383. https://doi. org/10.1136/jcp.2007.053317
• Torgbenu, E., Luckett, T., Buhagiar, M. A., & Phillips, J. L. (2023). Guidelines Relevant to Diagnosis, Assessment, and Management of Lymphedema: A Systematic Review. Advances in wound care, 12(1), 15–27. https://doi.org/10.1089/ wound.2021.0149
• Lebbé, C., Becker, J. C., & Cerroni, L. (2019). Kaposi sarcoma and other HHV8-related diseases. Annals of Oncology, 30(10), 1623–1634. https://doi. org/10.1093/annonc/mdz218
• Chang, A. Y., Karwa, R., Busakhala, N., Fletcher, S. L., Tonui, E. C., Wasike, P., et al. (2018). Randomized controlled trial to evaluate locally sourced two-component compression bandages for HIV-associated Kaposi sarcoma leg lymphedema in western Kenya: The Kenyan Improvised Compression for Kaposi Sarcoma (KICKS) study protocol. Contemporary Clinical Trials Communications, 12, 116–122. https:// doi.org/10.1016/j.conctc.2018.10.006
• Brambilla, L., Tourlaki, A., Ferrucci, S., Brambati, M., & Boneschi, V. (2006). Treatment of classic Kaposi's sarcomaassociated lymphedema with elastic stockings. The Journal of dermatology, 33(7), 451–456. https://doi.org/10.1111/j.1346- 8138.2006.00108.x
• Ersoz, C., et al. (2022). The evaluation of the importance of new immunohistochemical markers for the diagnosis and differential diagnosis of mesenchymal tumors. Journal of Medical Faculty Clinics, 5(1), 1–9.